We assign a fundamental rating of 2 out of 10 to AIMD. AIMD was compared to 35 industry peers in the Technology Hardware, Storage & Peripherals industry. AIMD has a bad profitability rating. Also its financial health evaluation is rather negative. AIMD does not seem to be growing, but still is valued expensively.

Quickly go to:

1. Profitability

2. Health

3. Growth

4. Valuation

5. Dividend

1. Profitability

1.1 Basic Checks

AIMD had negative earnings in the past year.
In the past year AIMD has reported a negative cash flow from operations.
AIMD had negative earnings in each of the past 5 years.
In the past 5 years AIMD always reported negative operating cash flow.

1.2 Ratios

With a Return On Assets value of -65.95%, AIMD is not doing good in the industry: 80.00% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of -148.90%, AIMD is in line with its industry, outperforming 42.86% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	-65.95%
ROE	-148.9%
ROIC	N/A

ROA(3y)-44.19%

ROA(5y)-139.96%

ROE(3y)-64.19%

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for AIMD so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

AIMD does not have a ROIC to compare to the WACC, probably because it is not profitable.
AIMD has more shares outstanding than it did 1 year ago.
The number of shares outstanding for AIMD has been increased compared to 5 years ago.
AIMD has a worse debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of -5.52, we must say that AIMD is in the distress zone and has some risk of bankruptcy.
AIMD has a Altman-Z score of -5.52. This is in the lower half of the industry: AIMD underperforms 74.29% of its industry peers.
AIMD has a Debt/Equity ratio of 1.10. This is a high value indicating a heavy dependency on external financing.
AIMD's Debt to Equity ratio of 1.10 is in line compared to the rest of the industry. AIMD outperforms 42.86% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	1.1
Debt/FCF	N/A
Altman-Z	-5.52

ROIC/WACCN/A

WACC4.36%

2.3 Liquidity

A Current Ratio of 2.96 indicates that AIMD has no problem at all paying its short term obligations.
With a decent Current ratio value of 2.96, AIMD is doing good in the industry, outperforming 80.00% of the companies in the same industry.
AIMD has a Quick Ratio of 2.67. This indicates that AIMD is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 2.67, AIMD belongs to the best of the industry, outperforming 85.71% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	2.96
Quick Ratio	2.67

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

AIMD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 68.99%, which is quite impressive.
Looking at the last year, AIMD shows a very strong growth in Revenue. The Revenue has grown by 178.57%.
AIMD shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 15.66% yearly.

EPS 1Y (TTM)68.99%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%60.51%

Revenue 1Y (TTM)178.57%

Revenue growth 3Y-67.26%

Revenue growth 5Y15.66%

Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.